Current treatment landscape of HR+/HER2- advanced breast cancer in the Nordics: a modified Delphi study.

Geisler, Jürgen; Karihtala, Peeter; Tuxen, Malgorzata; Valachis, Antonis; Holm, Barbro

Geisler, Jürgen; Karihtala, Peeter; Tuxen, Malgorzata; Valachis, Antonis; Holm, Barbro.

Afiliação

Geisler J; Department of Oncology, University of Oslo and Akershus University Hospital, Akershus, Norway.
Karihtala P; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Centre and University of Helsinki, Helsinki, Finland.
Tuxen M; Department of Oncology, University of Copenhagen Herlev Hospital, Copenhagen, Denmark.
Valachis A; Department of Oncology, Örebro University Hospital, Örebro, Sweden.
Holm B; Department of Oncology, Novartis, Stockholm, Sweden.

Acta Oncol ; 62(12): 1680-1688, 2023 Dec.

Article em En | MEDLINE | ID: mdl-37713138

Assuntos

Neoplasias Encefálicas; Neoplasias da Mama; Humanos; Feminino; Neoplasias da Mama/patologia; Técnica Delphi; Receptor ErbB-2/metabolismo; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Neoplasias Encefálicas/tratamento farmacológico

Palavras-chave

Delphi panel; HR+/HER2− aBC treatment strategies; HR+/HER2− advanced breast cancer; Nordic countries

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neoplasias da Mama Tipo de estudo: Guideline / Qualitative_research Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google